Partner Links Compare Wine Offers at MySuperMarket.co.uk Free online casino games at the all new realcazinoz.com Play online casino games for fun or rel money. No Deposit Casino Bonuses Play blackjack, roulette, slots and more free casino games at the all new casino las vegas online casino games for fun and real money gaming here at casino visa. More Links |
|
Related News Items
Pacira Pharmaceuticals, Inc. to Be Added to NASDAQ Biotechnology Index
Mon, 21 May 2012 03:30:00 -0700
Pacira Pharmaceuticals, Inc. today announced that it has been selected for inclusion in the NASDAQ Biotechnology Index® effective today. The National B
Read More...
New York Biotechnology Association to Honor Regeneron Founders as Business Leaders of the Year
Fri, 18 May 2012 05:45:00 -0700
New York Biotechnology Association , the voice of New York State’s bioscience industry, today announced that the 2012 honorees of the Association’s annual leadership awards will be the leaders of Regeneron Pharmaceuticals, New York’s largest biotechnology company: Dr.
Read More...
GenVec Appoints Cynthia Collins as President and CEO
Mon, 21 May 2012 04:30:00 -0700
GAITHERSBURG, Md., May 21, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that effective May 23, 2012 Cynthia Collins has been appointed as President and Chief Executive Officer. In addition, ...
Read More...
Spectrum Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
Tue, 08 May 2012 04:00:00 -0700
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the Bank of America Merrill Lynch 2012 Health Care Conference being held at Encore at the Wynn Hotel in Las Vegas, Nevada.
Read More...
Press Release
Mon, 21 May 2012 04:09:25 -0700
Pacira Pharmaceuticals Inc. Posted on:21 May 12 Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that it has been selected for inclusion in the NASDAQ Biotechnology Index® (NASDAQ: NBI) effective today.
Read More...
Infinity Added to NASDAQ Biotechnology Index
Tue, 15 May 2012 05:00:00 -0700
Infinity Pharmaceuticals, Inc. today announced that the company will be added to the NASDAQ Biotechnology Index® . The semi-annual re-ranking of the index will
Read More...
Spectrum Pharmaceuticals to Present at the Deutsche Bank 37th Annual Health Care Conference
Tue, 01 May 2012 04:00:00 -0700
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the 37th Annual Deutsche Bank Health Care Conference being held at The InterContinental Boston in Boston, Massachusetts.
Read More...
Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN® in Combination with the Redox Modulating Agent Motexafin ...
Thu, 17 May 2012 04:00:00 -0700
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN® Injection for intravenous use + rituximab in combination with motexafin gadolinium in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin ...
Read More...
Panel of Top Industry Executives to Discuss Biotech and Big Pharma – What’s Next? – 2012 BIO International Convention ...
Wed, 16 May 2012 13:54:00 -0700
The Biotechnology Industry Organization announced today that a panel of top industry executives will discuss where biotech will be in the next ten years and how the pharmaceutical industry landscape is changing.
Read More...
Spectrum Pharmaceuticals Expands Manufacturing Capacity and Builds Inventory Reserves for FUSILEV®
Mon, 23 Apr 2012 04:00:00 -0700
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that in order to meet the needs of cancer patients in the United States, the Company has substantially increased its manufacturing capacity of FUSILEV® for injection, since its approval for use in advanced metastatic ...
Read More...